eBook Key Considerations in Gene Therapy Manufacturing for Commercialization “The regulatory landscape for gene therapies is as transforming as...
Read moreArticles Posted by Peter Dellva
The Evolution of Therapeutic Monoclonal Antibodies
By Tracy TreDenick, Head of Regulatory and Quality, and Senior Consultant, BioTechLogic The elegant simplicity of monoclonal antibodies (mAbs) has catapulted them to a...
FDA Seeking to Enhance Manufacturing of Cell Therapy and Gene Therapy Products
More consistent and reliable production cell therapy and gene therapy processes are critical for advancing innovative treatments. While cell therapy and gene therapy...
Gene Therapy for Rare Disorders Becoming Viable
Resurgent across the biomedical engineering and clinical trial landscape, gene therapy owes its new vitality to a better understanding of rare diseases, the discovery...
Six Fascinating Life Sciences AI Applications
Where is life sciences AI heading? More is better when it comes to Big Data and machine learning. This is particularly true in the fields of medicine and pharma. A...
Recent Posts
- Top 25 Biotech Companies of 2024
- The EU Clinical Trials Regulation – Experiences from the First 18 Months
- CMC Expertise Accelerating Biologics Development for 20 Years and Counting
- Strengthening Your Gene Therapy Process Control Strategy
- Designing a Gene Therapy CMC Architecture for the Full Product Lifecycle